| Literature DB >> 20042449 |
Catharina Nesselmann1, Wenzhong Li, Nan Ma, Gustav Steinhoff.
Abstract
Accumulating clinical and experimental evidence indicates that stem cells from various sources are promising in the treatment of cardiac dysfunction. They may be incorporated into neovascular foci and thus contribute to postnatal physiological and pathological vasculogenesis and/or produce a variety of growth factors for angiogenesis and cytokines that home other stem cells from other organs for cardiac regeneration. This review focuses on the neovascularization of stem cells from different sources in cardiac repair, with emphasis on adult stem cells.Entities:
Mesh:
Substances:
Year: 2009 PMID: 20042449 DOI: 10.1177/1753944709353338
Source DB: PubMed Journal: Ther Adv Cardiovasc Dis ISSN: 1753-9447